Vitamin D deficiency is independently associated with the extent of coronary artery disease

European Journal of Clinical Investigation

Volumn 44, Issue 7, 2014, Pages 634-642

  Verdoia, Monica ^a   Schaffer, Alon ^a   Sartori, Chiara ^a   Barbieri, Lucia ^a   Cassetti, Ettore ^a   Marino, Paolo ^a   Galasso, Gennaro ^b   De Luca, Giuseppe ^a  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Coronary angiography; Coronary artery disease; Vitamin D

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIURETIC AGENT; HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CALCIFEDIOL; CALCIUM CHANNEL BLOCKING AGENT;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; THROMBOCYTE COUNT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; AGE; BLOOD; COMPLICATION; DEFICIENCY; METABOLISM; SEX DIFFERENCE;

ADRENERGIC BETA-ANTAGONISTS; AGE FACTORS; AGED; CALCIFEDIOL; CALCIUM CHANNEL BLOCKERS; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; DIURETICS; FEMALE; HEMOGLOBINS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PLATELET COUNT; SEX FACTORS; TRIGLYCERIDES; VITAMIN D DEFICIENCY;

EID: 84903395757     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12281     Document Type: Article

References (42)

1. De Luca G, Cassetti E, Marino P. Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction. Am J Emerg Med 2009;27:712-9.
2. De Luca G, Bellandi F, Huber K, Noc M, Petronio AS, Arntz HR et al. Early glycoprotein IIb-IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient's data meta-analysis. J Thromb Haemost 2011;9:2361-70.
3. De Luca G, Santagostino M, Secco GG, Cassetti E, Giuliani L, Franchi E et al. Mean platelet volume and the extent of coronary artery disease: results from a large prospective study. Atherosclerosis 2009;206:292-7.
4. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008;168:1174-80.
5. Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009;57:1595-603.
6. Pilz S, Marz W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin Endocrinol Metab 2008;93:3927-35.
7. Buitrago CG, Arango NS, Boland RL. 1α, 25(OH)2D3-dependent modulation of Akt in proliferating and differentiating C2C12 skeletal muscle cells. J Cell Biochem 2012;113:1170-81.
8. van Etten E, Mathieu C. Immunoregulation by 1, 25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005;97:93-101.
9. Silvagno F, De Vivo E, Attanasio A, Gallo V, Mazzucco G, Pescarmona G. Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes. PLoS ONE 2010;5:e8670.
10. Forman JP, Bischoff-Ferrari HA, Willett WC, Stampfer MJ, Curhan GC. Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension 2005;46:676-82.
11. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-29.
12. Lamendola CA, Ariel D, Feldman D, Reaven GM. Relations between obesity, insulin resistance, and 25-hydroxyvitamin D. Am J Clin Nutr 2012;95:1055-105.
13. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005;28:1228-30.
14. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-357.
15. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
16. Vierucci F, Del Pistoia M, Fanos M, Gori M, Carlone G, Erba P et al. status and predictors of hypovitaminosis D in Italian children and adolescents: a cross-sectional study. Eur J Pediatr 2013;172:1607-17.
17. Yong AS, Ng AC, Brieger D, Lowe HC, Ng MK, Kritharides L. Three-dimensional and two-dimensional quantitative coronary angiography, and their prediction of reduced fractional flow reserve. Eur Heart J 2011;32:345-53.
18. De Luca G, van 't Hof AW, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH et al. Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Eur Heart J 2005;26:662-6.
19. De Luca G, Ernst N, van 't Hof AW, Ottervanger JP, Hoorntje JC, Gosselink AT et al. Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction. Am Heart J 2006;151:1256-9.
20. Grant WB, Cross HS, Garland CF, Gorham ED, Moan J, Peterlik M et al. Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Prog Biophys Mol Biol 2009;99:104-13.
21. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet. The Lancet 1989;2:1104-5.
22. Holick MF, MacLaughlin JA, Doppelt SH Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. Science 1981;211:590-3.
23. Rostand SG, Drueke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 1999;56:383-92.
24. Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab 2009;94:4023-30.
25. Cardus A, Panizo S, Encinas M, Dolcet X, Gallego C, Aldea M et al. 1, 25-dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter. Atherosclerosis 2009;204:85-9.
26. Norman PE, Powell JT. Vitamin D, shedding light on the development of disease in peripheral arteries. Arterioscler Thromb Vasc Biol 2005;25:39-46.
27. Schleithoff SS, Zittermann A, Tenderich G, Berthold HK, Stehle P, Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006;83:754-9.
28. Aihara K, Azuma H, Akaike M, Ikeda Y, Yamashita M, Sudo T et al. Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem 2004;279:35798-802.
29. Sigmund CD. Regulation of renin expression and blood pressure by vitamin D(3). J Clin Invest 2002;110:155-6.
30. Barreto DV, Barreto FC, Liabeuf S, Temmar M, Boitte F, Choukroun G et al. Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol 2009;4:1128-35.
31. Jono S, Nishizawa Y, Shioi A, Morii H. 1, 25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 1998;98:1302-6.
32. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997;96:1755-60.
33. Robinson-Cohen C, Hoofnagle AN, Ix JH, Sachs MC, Tracy RP, Siscovick DS et al. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA 2013;310:179-88.
34. Shanker J, Maitra A, Arvind P, Nair J, Dash D, Manchiganti R et al. Role of vitamin D levels and vitamin D receptor polymorphisms in relation to coronary artery disease: the Indian atherosclerosis research study. Coron Artery Dis 2011;22:324-32.
35. Goleniewska BM, Kacprzak M, Zielinska M. Vitamin D level and extent of coronary stenotic lesions in patients with first acute myocardial infarction. Cardiol J 2014;21:18-23.
36. Deng X, Song Y, Manson JE, Signorello LB, Zhang SM, Shrubsole MJ et al. Magnesium, vitamin D status and mortality: results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III. BMC Med 2013;11:187.
37. Witham MD, Dove FJ, Sugden JA, Doney AS, Struthers AD. The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial. Nutr Metab Cardiovasc Dis 2012;22:864-70.
38. Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med 2008;25:320-5.
39. Sokol SI, Srinivas V, Crandall JP, Kim M, Tellides G, Lebastchi AH et al. The effects of vitamin D repletion on endothelial function and inflammation in patients with coronary artery disease. Vasc Med 2012;17:394-404.
40. Elamin MB, Abu Elnour NO, Elamin KB, Fatourechi MM, Alkatib AA, Almandoz JP et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011;96:1931-42.
41. Gezmish O, Black MJ. Vitamin d deficiency in early life and the potential programming of cardiovascular disease in adulthood. J Cardiovasc Transl Res 2013;6:588-603.
42. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369:1991-2000.